AM 374
AM 374 is an fatty acid amide hydrolase (FAAH) inhibitor. AM 374 inhibits amidase activity with an IC50 value of 13 nM. AM 374 can be used for the research of neurological disease[1][2].
Product Specifications
CAS Number
86855-26-7
UNSPSC
12352100
Hazard Statement
H290, H314
Target
FAAH
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/am-374.html
Concentration
10mM
Purity
97.0
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
CCCCCCCCCCCCCCCCS(=O)(F)=O
Molecular Formula
C16H33FO2S
Molecular Weight
308.50
Precautions
H290, H314
References & Citations
[1]Deutsch DG, et al. Fatty acid sulfonyl fluorides inhibit anandamide metabolism and bind to the cannabinoid receptor. Biochem Biophys Res Commun. 1997 Feb 3;231 (1) :217-21.|[2]Arizzi MN, et al. Behavioral effects of inhibition of cannabinoid metabolism: The amidase inhibitor AM374 enhances the suppression of lever pressing produced by exogenously administered anandamide. Life Sci. 2004 Jan 9;74 (8) :1001-11.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC883793-500 1x 500 µL
Erythropoietin (EPO) (Marker of Placentation Disorders) (EPO/3793R), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC401932-100 1x 100 µL
CD44v4 (Marker of Tumor Metastasis) (rCD44v4/1219), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
